LARGO, Fla., Nov. 14 /PRNewswire-FirstCall/ -- GeoPharma, Inc. today announced financial results for the three months ended September 30, 2007. "Although, the second quarter proved to be a challenging one for GeoPharma, many recent positive developments allow the company to look forward with continued confidence and optimism", stated GeoPharma CEO Mihir K. Taneja. "Two major developments for the Company including the completion of the Dynamic Health Products Inc. ("Dynamic") acquisition, as well as the FDA approval of our first generic drug offering, Carprofen, are prime examples of the company's growing advancement opportunities". "We maintain the belief that GeoPharma is well positioned to finish the year strongly, with new manufacturing contracts coming online, the overhead inventory supply of a major manufacturing client eliminated and the addition of new revenues and income generated from manufacturing Carprofen and the Dynamic acquisition". "Furthermore, we continue to make progress on the 12 ANDAs as well as other drug products in the pipeline". "The company will obviously expound on all new developments as they reveal themselves in the next 1, 3, and 6 month periods".
ABOUT GEOPHARMA, INC.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company's growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma's competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at www.geopharmainc.com, www.onlineihp.com and www.hoodiadexl10.com
CONFERENCE CALL INFORMATION
GeoPharma will host a conference call to discuss results on Wednesday, November 14, 2007 at 11:30 (ET) with CEO, Mihir Taneja and VP/CFO, Carol Dore- Falcone. Interested parties may participate in the conference call by dialing 1-866-831-6234 and entering pass code 35259037, 5 minutes prior to the initiation of the call. A replay of the conference call will be available from 1:30 PM (ET) on November 14 through November 21, by dialing 1-888-286- 8010 and entering pass code 38097544.
FORWARD LOOKING STATEMENTS
This press release may contain statements, which constitute forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries' expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company's management as of the date hereof, and actual results may vary based upon future events, both within and without management's control. Important factors that could cause such differences are described in the company's periodic filings with the Securities and Exchange Commission.
CONTACT: Carol Dore-Falcone, VP-CFO, GeoPharma, Inc., +1-727-471-0850,
ext. 243, IR@GeoPharmainc.com
Web site: http://www.geopharmainc.com/
http://www.onlineihp.com/
